Just look around, and you’ll see America’s obesity epidemic in plain sight. In New York State, the percentage of adults classified as obese has nearly doubled in the last 25 years, from 16% to 30%.

Munich Re reveals the effects of medications, like Ozempic and Wegovy, on mortality rates and life insurance underwriting.

Glucagon-like peptide-1 (GLP-1) receptor agonist medications like semaglutide (Wegovy) and tirzepatide (Zepbound) are some of the most talked about weight loss options out there. But without insurance ...

A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity medications, according to a new University of Michigan study. And more than half of ...